Armata Pharmaceuticals, Inc. (ARMP) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts ARMP Hot Sheet
Join SI Premium – FREE
Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q2 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.17 million versus the consensus estimate of $1.38 million.
For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Upgrades Titan Machinery (TITN) to Outperform
- BofA Securities Downgrades Ming Yuan Cloud Group Holdings Ltd (909:HK) to Underperform
- Baird Upgrades AGCO Corporation (AGCO) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
